IRIS
ESPOSITO, PASQUALE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.408
Totale 8.408
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 8.408
Totale 8.408
Salva come PNG Salva come JPEG
Città #
Genova 5.012
Genoa 1.297
Vado Ligure 1.228
Rapallo 844
Bordighera 27
Totale 8.408
Salva come PNG Salva come JPEG
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 170
Radiocontrast media cause dephosphorylation of Akt and downstream signalingtargets in human renal proximal tubular cells 150
Soluble Toll-like Receptor 4: A New Player in Subclinical Inflammation and Malnutrition in Hemodialysis Patients 144
Risk factors for kidney diseases and awareness of blood pressure and proteinuria in general population and in high school students: Italian report for World Kidney Days 2012-2013 122
Modulation of Myostatin/Hepatocyte Growth Factor Balance by Different Hemodialysis Modalities 116
Costimulatory blockade: A novel approach to the treatment of glomerular disease? 104
THE EFFECTS OF DIFFERENT DIALYSIS TREATMENTS ON GLYCEMIC EXCURSIONS AND INFLAMMATION IN PATIENTS WITH END-STAGE RENAL DISEASE WITH AND WITHOUT TYPE 2 DIABETES MELLITUS 102
Awareness of kidney diseases in general population and in high school students. Italian report for World Kidney Days 2010-2011 95
Hepatocyte growth factor (HGF) and hemodialysis: physiopathology and clinical implications 94
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 92
Mesenchymal Stromal Cells Prevent Renal Fibrosis in a Rat Model of Unilateral Ureteral Obstruction by Suppressing the Renin-Angiotensin System via HuR 87
Costimulatory pathways in kidney transplantation: pathogenetic role, clinical significance and new therapeutic opportunities 87
REPORT SUI DATI RACCOLTI DURANTE LA GIORNATA MONDIALE DEL RENE IN ITALIA NEGLI ANNI 2015-2016- Report for the World Kidney Days in Italy 2015-2016 86
Significance of serum Myostatin in hemodialysis patients 83
Bicarbonate dialysis compared to hemodiafiltration on glycemic excursions in patients with end-stage renal disease with and without type 2 diabetes mellitus 82
Perfusion of isolated rat kidney with Mesenchymal Stromal Cells/Extracellular Vesicles prevents ischaemic injury 82
Acute kidney injury: effect of hemodialysis membrane on Hgf and recovery of renal function 81
Clinical audit, a valuable tool to improve quality of care: General methodology and applications in nephrology 80
ANCA-associated vasculitis in childhood: Recent advances 79
Effects of two different dialytic treatments on inflammatory markers in people with end-stage renal disease with and without type 2 diabetes mellitus 79
EFFECTS OF DIALYSIS MODALITY ON MYOSTATIN/HGF BALANCE IN REGULAR HD PATIENTS 78
The syndrome of inappropriate antidiuresis: pathophysiology, clinical management and new therapeutic options 77
Assessment of physical performance and quality of life in kidney-transplanted patients: a cross-sectional study 77
CD40/SCD40 imbalance in hemodialysis patients 76
Global Performance Status Score: A New Tool to Assess Physical Performance in Kidney Transplant Patients 76
Brief Report: A Case of Tramadol Overdose: Extracorporeal Life Support and Hemoperfusion as Life-Saving Treatment 73
Effects of different peritoneal dialysis fluids on the TH1/TH2 balance 72
Antineutrophil cytoplasmic antibody- associated renal vasculitis treated with autologous mesenchymal stromal cells: Evaluation of the contribution of immune-mediated mechanisms 72
Rhabdomyolysis-Associated Acute Kidney Injury 71
Activin/myostatin receptor signaling and vascular calcifications in chronic kidney disease: A "liaison dangereuse"? 71
RBP4: A Culprit for Insulin Resistance in End Stage Renal Disease That Can Be Cleared by Hemodiafiltration 70
CD40/CD40L and cardiovascular risk in patients on haemodialysis: a role for soluble CD40? 70
Understanding Bone Damage After Kidney Transplantation: A Retrospective Monocentric Cross Sectional Analysis 69
Management of mineral metabolism in haemodialysis patients: need for new strategies 68
Vitamin D in kidney transplant recipients
. 68
Renal diseases in haemophilic patients: pathogenesis and clinical management 68
Living Kidney Donation Is Recipient Age Sensitive and Has a High Rate of Donor Organ Disqualifications 68
Massive liver polycystic disease in a kidney transplanted patient 67
Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics 67
Rituximab in primary membranous nephropathy: beyond a B-cell-centered paradigm? 66
Vitamin e-loaded membrane dialyzers reduce hemodialysis inflammaging 66
Clinical audit improves hypertension control in hemodialysis patients 66
Myostatin in the Arterial Wall of Patients with End-Stage Renal Disease 66
Management of mineral metabolism in hemodialysis patients: discrepancy between interventions and perceived causes of failure 66
#6111 FIRST IDENTIFICATION AND CHARACTERIZATION OF MICROPLASTICS IN HUMAN KIDNEY AND URINE 66
Potential role of costimulatory pathways in immune dysfunction in hemodialysis patients 65
Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients 65
Oxidative stress and inflammation: Implications in uremia and hemodialysis 65
Trained breathing-induced oxygenation acutely reverses cardiovascular autonomic dysfunction in patients with type 2 diabetes and renal disease. 64
Mechanisms underlying sCD40 production in hemodialysis patients 64
New Treatment Options for Hyperkalemia in Patients with Chronic Kidney Disease 64
Ten-Year Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant: A Prospective Cohort Study 64
Huge kidneys in a patient with chronic lymphocytic leukaemia 63
A Narrative Review on C3 Glomerulopathy: A Rare Renal Disease 63
Low protein diets and plant-based low protein diets: Do they meet protein requirements of patients with chronic kidney disease? 63
Soluble CD40 as a modulator of CD40 pathway 62
Impact of seropositivity to Chlamydia pneumoniae and anti-hHSP60 on cardiovascular events in hemodialysis patients 62
Mesenchymal stromal cells reset the scatter factor system and cytokine network in experimental kidney transplantation 62
Kinetics of T-lymphocyte subsets and posttransplant opportunistic infections in heart and kidney transplant recipients 62
In Reply to 'A Possible Mechanism for Severe Symptomatic Hyponatremia During Sibutramine Therapy' 61
Erythema nodosum in kidney transplant recipient: a rare complication of pneumonia treatment 61
Multiple electrolyte disorders in a neurosurgical patient: solving the rebus 61
Mesenchymal stromal cells improve renal injury in anti-Thy 1 nephritis by modulating inflammatory cytokines and scatter factors 61
The role of therapeutic drug monitoring in the treatment of cytomegalovirus disease in kidney transplantation 60
Autoimmune response to heat shock protein 60 in haemodialysis patients 60
Effects of Different Dialysis Strategies on Inflammatory Cytokine Profile in Maintenance Hemodialysis Patients with COVID-19: A Randomized Trial 59
Early allograft calcifications after kidney transplantation 59
Selective bilirubin removal: a treatment of jaundice-related kidney injury? 59
null 59
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 59
Peritonitis in type 2 diabetes mellitus due to Ochrobactrum anthropi complicating automated peritoneal dialysis 58
Ganciclovir-resistant cytomegalovirus infection in transplanted patients: utility of drug monitoring 58
GM-CSF contributes to prompt healing of ecthyma gangrenosum lesions in kidney transplant recipient 58
Saquinavir in steroid-dependent and -resistant nephrotic syndrome: a pilot study 58
Nutritional Challenges in Pregnant Women with Renal Diseases: Relevance to Fetal Outcomes 56
"Deep" purple urine bag syndrome: physiopathology and clinical implications 54
Sirolimus vs cyclosporine after induction with basiliximab does not promote regulatory T cell expansion in de novo kidney transplantation: Results from a single-center randomized trial 53
Revascularization for renal-artery stenosis 52
Renal involvement in mushroom poisoning: The case of Orellanus syndrome 52
Fetuin-A gene expression, synthesis and release in primary human hepatocytes cultured in a galactosylated membrane bioreactor 52
Muscle protein turnover and low-protein diets in patients with chronic kidney disease 52
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study 52
Central line-associated bloodstream infections in hemodialysis patients in the COVID-19 era 52
Microplastics and Kidneys: An Update on the Evidence for Deposition of Plastic Microparticles in Human Organs, Tissues and Fluids and Renal Toxicity Concern 52
How to Overcome Anabolic Resistance in Dialysis-Treated Patients? 50
Interleukin-6 release from peripheral mononuclear cells is associated to disease activity and treatment response in patients with lupus nephritis 49
Ultrasonography of Quadriceps Femoris Muscle and Subcutaneous Fat Tissue and Body Composition by BIVA in Chronic Dialysis Patients 49
null 49
Myostatin: Basic biology to clinical application 49
Downregulation of cell survival signalling pathways and increased cell damage in hydrogen peroxide-treated human renal proximal tubular cells by alpha-erythropoietin 48
Once-weekly hemodialysis: a single-center experience 48
Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood 48
Fructose and uric acid: Major mediators of cardiovascular disease risk starting at pediatric age 47
Inhibition of Ras/ERK1/2 signaling protects against postischemic renal injury 47
Severe symptomatic hyponatremia during sibutramine therapy: a case report 46
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis 46
An Updated Focus on Immune Checkpoint Inhibitors and Tubulointerstitial Nephritis 45
The role of interleukin-6 and of its soluble receptors in the biocompatibility of dialysis treatment 45
Inflammation may modulate IL-6 and C-reactive protein gene expression in the adipose tissue: the role of IL-6 cell membrane receptor 44
null 44
Totale 6.829
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.175
article - articoli 40.473
book - libri 0
conference - conferenze 474
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.228
Totale 84.350
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.391 0 0 0 0 0 271 687 299 314 465 294 61
2020/20211.325 85 100 94 197 94 94 113 127 81 167 64 109
2021/20221.431 48 83 35 106 74 75 107 346 144 174 50 189
2022/20231.138 142 58 27 59 130 124 61 106 224 52 118 37
2023/2024979 39 69 56 133 88 151 47 72 53 27 65 179
2024/20251.411 99 244 109 135 448 376 0 0 0 0 0 0
Totale 8.819